
Artificial intelligence is massively utilized in genomics for developing & exploring novel medicines for curing rare ailments. Moreover, it makes use of various DNA sequencing procedures, bioinformatics, and recombinant DNAs for assembling, sequencing, analyzing, and functioning of genomes.
The global Artificial Intelligence In Genomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.68%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence In Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence In Genomics.
Report Scope
The Artificial Intelligence In Genomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence In Genomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence In Genomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Deep Genomics
IBM
FDNA Inc.
Microsoft
Genoox Ltd.
NVIDIA Corporation
Lifebit
BenevolentAI
Cambridge Cancer Genomics
Fabric Genomics Inc.
Verge Genomics
SOPHiA GENETICS
Freenome Holdings, Inc.
MolecularMatch Inc.
Data4Cure Inc.
PrecisionLife Ltd
Diploid
DNAnexus Inc.
Segment by Type
Machine Learning
Computer Vision
Segment by Application
Pharma
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence In Genomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence In Genomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Machine Learning
1.2.3 Computer Vision
1.3 Market by Application
1.3.1 Global Artificial Intelligence In Genomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharma
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence In Genomics Market Perspective (2019-2030)
2.2 Artificial Intelligence In Genomics Growth Trends by Region
2.2.1 Global Artificial Intelligence In Genomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence In Genomics Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence In Genomics Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence In Genomics Market Dynamics
2.3.1 Artificial Intelligence In Genomics Industry Trends
2.3.2 Artificial Intelligence In Genomics Market Drivers
2.3.3 Artificial Intelligence In Genomics Market Challenges
2.3.4 Artificial Intelligence In Genomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence In Genomics Players by Revenue
3.1.1 Global Top Artificial Intelligence In Genomics Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence In Genomics Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence In Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence In Genomics Revenue
3.4 Global Artificial Intelligence In Genomics Market Concentration Ratio
3.4.1 Global Artificial Intelligence In Genomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence In Genomics Revenue in 2023
3.5 Artificial Intelligence In Genomics Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence In Genomics Product Solution and Service
3.7 Date of Enter into Artificial Intelligence In Genomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence In Genomics Breakdown Data by Type
4.1 Global Artificial Intelligence In Genomics Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence In Genomics Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence In Genomics Breakdown Data by Application
5.1 Global Artificial Intelligence In Genomics Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence In Genomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence In Genomics Market Size (2019-2030)
6.2 North America Artificial Intelligence In Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence In Genomics Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence In Genomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence In Genomics Market Size (2019-2030)
7.2 Europe Artificial Intelligence In Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence In Genomics Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence In Genomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence In Genomics Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence In Genomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence In Genomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence In Genomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence In Genomics Market Size (2019-2030)
9.2 Latin America Artificial Intelligence In Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence In Genomics Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence In Genomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence In Genomics Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence In Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence In Genomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence In Genomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Deep Genomics
11.1.1 Deep Genomics Company Detail
11.1.2 Deep Genomics Business Overview
11.1.3 Deep Genomics Artificial Intelligence In Genomics Introduction
11.1.4 Deep Genomics Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.1.5 Deep Genomics Recent Development
11.2 IBM
11.2.1 IBM Company Detail
11.2.2 IBM Business Overview
11.2.3 IBM Artificial Intelligence In Genomics Introduction
11.2.4 IBM Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.2.5 IBM Recent Development
11.3 FDNA Inc.
11.3.1 FDNA Inc. Company Detail
11.3.2 FDNA Inc. Business Overview
11.3.3 FDNA Inc. Artificial Intelligence In Genomics Introduction
11.3.4 FDNA Inc. Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.3.5 FDNA Inc. Recent Development
11.4 Microsoft
11.4.1 Microsoft Company Detail
11.4.2 Microsoft Business Overview
11.4.3 Microsoft Artificial Intelligence In Genomics Introduction
11.4.4 Microsoft Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.4.5 Microsoft Recent Development
11.5 Genoox Ltd.
11.5.1 Genoox Ltd. Company Detail
11.5.2 Genoox Ltd. Business Overview
11.5.3 Genoox Ltd. Artificial Intelligence In Genomics Introduction
11.5.4 Genoox Ltd. Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.5.5 Genoox Ltd. Recent Development
11.6 NVIDIA Corporation
11.6.1 NVIDIA Corporation Company Detail
11.6.2 NVIDIA Corporation Business Overview
11.6.3 NVIDIA Corporation Artificial Intelligence In Genomics Introduction
11.6.4 NVIDIA Corporation Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.6.5 NVIDIA Corporation Recent Development
11.7 Lifebit
11.7.1 Lifebit Company Detail
11.7.2 Lifebit Business Overview
11.7.3 Lifebit Artificial Intelligence In Genomics Introduction
11.7.4 Lifebit Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.7.5 Lifebit Recent Development
11.8 BenevolentAI
11.8.1 BenevolentAI Company Detail
11.8.2 BenevolentAI Business Overview
11.8.3 BenevolentAI Artificial Intelligence In Genomics Introduction
11.8.4 BenevolentAI Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.8.5 BenevolentAI Recent Development
11.9 Cambridge Cancer Genomics
11.9.1 Cambridge Cancer Genomics Company Detail
11.9.2 Cambridge Cancer Genomics Business Overview
11.9.3 Cambridge Cancer Genomics Artificial Intelligence In Genomics Introduction
11.9.4 Cambridge Cancer Genomics Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.9.5 Cambridge Cancer Genomics Recent Development
11.10 Fabric Genomics Inc.
11.10.1 Fabric Genomics Inc. Company Detail
11.10.2 Fabric Genomics Inc. Business Overview
11.10.3 Fabric Genomics Inc. Artificial Intelligence In Genomics Introduction
11.10.4 Fabric Genomics Inc. Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.10.5 Fabric Genomics Inc. Recent Development
11.11 Verge Genomics
11.11.1 Verge Genomics Company Detail
11.11.2 Verge Genomics Business Overview
11.11.3 Verge Genomics Artificial Intelligence In Genomics Introduction
11.11.4 Verge Genomics Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.11.5 Verge Genomics Recent Development
11.12 SOPHiA GENETICS
11.12.1 SOPHiA GENETICS Company Detail
11.12.2 SOPHiA GENETICS Business Overview
11.12.3 SOPHiA GENETICS Artificial Intelligence In Genomics Introduction
11.12.4 SOPHiA GENETICS Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.12.5 SOPHiA GENETICS Recent Development
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Detail
11.13.2 Freenome Holdings, Inc. Business Overview
11.13.3 Freenome Holdings, Inc. Artificial Intelligence In Genomics Introduction
11.13.4 Freenome Holdings, Inc. Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.13.5 Freenome Holdings, Inc. Recent Development
11.14 MolecularMatch Inc.
11.14.1 MolecularMatch Inc. Company Detail
11.14.2 MolecularMatch Inc. Business Overview
11.14.3 MolecularMatch Inc. Artificial Intelligence In Genomics Introduction
11.14.4 MolecularMatch Inc. Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.14.5 MolecularMatch Inc. Recent Development
11.15 Data4Cure Inc.
11.15.1 Data4Cure Inc. Company Detail
11.15.2 Data4Cure Inc. Business Overview
11.15.3 Data4Cure Inc. Artificial Intelligence In Genomics Introduction
11.15.4 Data4Cure Inc. Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.15.5 Data4Cure Inc. Recent Development
11.16 PrecisionLife Ltd
11.16.1 PrecisionLife Ltd Company Detail
11.16.2 PrecisionLife Ltd Business Overview
11.16.3 PrecisionLife Ltd Artificial Intelligence In Genomics Introduction
11.16.4 PrecisionLife Ltd Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.16.5 PrecisionLife Ltd Recent Development
11.17 Diploid
11.17.1 Diploid Company Detail
11.17.2 Diploid Business Overview
11.17.3 Diploid Artificial Intelligence In Genomics Introduction
11.17.4 Diploid Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.17.5 Diploid Recent Development
11.18 DNAnexus Inc.
11.18.1 DNAnexus Inc. Company Detail
11.18.2 DNAnexus Inc. Business Overview
11.18.3 DNAnexus Inc. Artificial Intelligence In Genomics Introduction
11.18.4 DNAnexus Inc. Revenue in Artificial Intelligence In Genomics Business (2019-2024)
11.18.5 DNAnexus Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Deep Genomics
IBM
FDNA Inc.
Microsoft
Genoox Ltd.
NVIDIA Corporation
Lifebit
BenevolentAI
Cambridge Cancer Genomics
Fabric Genomics Inc.
Verge Genomics
SOPHiA GENETICS
Freenome Holdings, Inc.
MolecularMatch Inc.
Data4Cure Inc.
PrecisionLife Ltd
Diploid
DNAnexus Inc.
Ìý
Ìý
*If Applicable.
